跳至主要内容
临床试验/NCT07070557
NCT07070557尚未招募不适用

High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated With Poor Survival in Patients With Hemodialysis

Sohag University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年7月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
试验地点
1
主要终点
Mortality

研究概览

简要总结

To explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Months 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All cases with age ≥ 18 years from both sexes female and male, having end-stage renal disease (ESRD), who have been on hemodialysis for at least three months and divided to 4 groups according to the median of NLR and PLR

排除标准

  • • Patients aged < 18 years old.
  • Patient with autoimmune disease.
  • Patient with liver cirrhosis.
  • Patients with immunodeficiency.
  • Patients with malignancy.

结局指标

主要结局

Mortality

时间窗: 6 months

The primary outcome measures in the study "High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis" is :- All-cause mortality, encompassing death from any cause These is the endpoint used to evaluate the prognostic significance of NLR and PLR in hemodialysis patients.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bassem Ayman Mohamed

resident in internal medicine department

Sohag University

研究点 (1)

Loading locations...

相似试验

High Neutrophil-to-Lymphocyte Ratio and Patients... | 临床试验